These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Dopaminergic augmentation of delta-9-tetrahydrocannabinol (THC) discrimination: possible involvement of D(2)-induced formation of anandamide. Solinas M, Tanda G, Wertheim CE, Goldberg SR. Psychopharmacology (Berl); 2010 Apr; 209(2):191-202. PubMed ID: 20179908 [Abstract] [Full Text] [Related]
5. Phenotypic assessment of THC discriminative stimulus properties in fatty acid amide hydrolase knockout and wildtype mice. Walentiny DM, Vann RE, Wiley JL. Neuropharmacology; 2015 Jun; 93():237-42. PubMed ID: 25698527 [Abstract] [Full Text] [Related]
6. (R)-methanandamide and Delta 9-THC as discriminative stimuli in rats: tests with the cannabinoid antagonist SR-141716 and the endogenous ligand anandamide. Järbe TU, Lamb RJ, Lin S, Makriyannis A. Psychopharmacology (Berl); 2001 Aug; 156(4):369-80. PubMed ID: 11498713 [Abstract] [Full Text] [Related]
7. Nicotinic, muscarinic and dopaminergic actions in the ventral hippocampus and the nucleus accumbens: effects on spatial working memory in rats. Kim JS, Levin ED. Brain Res; 1996 Jul 01; 725(2):231-40. PubMed ID: 8836529 [Abstract] [Full Text] [Related]
8. A comparison of the discriminative stimulus effects of delta(9)-tetrahydrocannabinol and O-1812, a potent and metabolically stable anandamide analog, in rats. Wiley JL, LaVecchia KL, Karp NE, Kulasegram S, Mahadevan A, Razdan RK, Martin BR. Exp Clin Psychopharmacol; 2004 Aug 01; 12(3):173-9. PubMed ID: 15301634 [Abstract] [Full Text] [Related]
10. Discriminative stimulus properties of delta9-tetrahydrocannabinol (THC) in C57Bl/6J mice. Vann RE, Warner JA, Bushell K, Huffman JW, Martin BR, Wiley JL. Eur J Pharmacol; 2009 Aug 01; 615(1-3):102-7. PubMed ID: 19470387 [Abstract] [Full Text] [Related]
11. Dopaminergic and cholinergic involvement in the discriminative stimulus effects of nicotine and cocaine in rats. Desai RI, Barber DJ, Terry P. Psychopharmacology (Berl); 2003 Jun 01; 167(4):335-43. PubMed ID: 12684733 [Abstract] [Full Text] [Related]
13. Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB1 receptor-mediated discriminative stimulus in mice. Owens RA, Mustafa MA, Ignatowska-Jankowska BM, Damaj MI, Beardsley PM, Wiley JL, Niphakis MJ, Cravatt BF, Lichtman AH. Neuropharmacology; 2017 Oct 01; 125():80-86. PubMed ID: 28673548 [Abstract] [Full Text] [Related]
14. Endocannabinoid contribution to Δ9-tetrahydrocannabinol discrimination in rodents. Wiley JL, Walentiny DM, Wright MJ, Beardsley PM, Burston JJ, Poklis JL, Lichtman AH, Vann RE. Eur J Pharmacol; 2014 Aug 15; 737():97-105. PubMed ID: 24858366 [Abstract] [Full Text] [Related]
15. Dorsal hippocampal muscarinic and nicotinic receptors are involved in mediating morphine reward. Rezayof A, Zatali H, Haeri-Rohani A, Zarrindast MR. Behav Brain Res; 2006 Jan 30; 166(2):281-90. PubMed ID: 16191443 [Abstract] [Full Text] [Related]
16. Evaluation of cannabimimetic discriminative stimulus effects of anandamide and methylated fluoroanandamide in rhesus monkeys. Wiley JL, Golden KM, Ryan WJ, Balster RL, Razdan RK, Martin BR. Pharmacol Biochem Behav; 1997 Dec 30; 58(4):1139-43. PubMed ID: 9408225 [Abstract] [Full Text] [Related]
17. 5-HT1A receptors are involved in the anxiolytic effect of Delta9-tetrahydrocannabinol and AM 404, the anandamide transport inhibitor, in Sprague-Dawley rats. Braida D, Limonta V, Malabarba L, Zani A, Sala M. Eur J Pharmacol; 2007 Jan 26; 555(2-3):156-63. PubMed ID: 17116299 [Abstract] [Full Text] [Related]
18. Self-administration of the anandamide transport inhibitor AM404 by squirrel monkeys. Schindler CW, Scherma M, Redhi GH, Vadivel SK, Makriyannis A, Goldberg SR, Justinova Z. Psychopharmacology (Berl); 2016 May 26; 233(10):1867-77. PubMed ID: 26803499 [Abstract] [Full Text] [Related]
20. Nicotinic and muscarinic acetylcholine receptors are essential for the long-term response of tyrosine hydroxylase gene expression to chronic nicotine treatment in rat adrenal medulla. Yoshimura R, Xu L, Sun B, Tank AW. Brain Res Mol Brain Res; 2004 Jul 26; 126(2):188-97. PubMed ID: 15249143 [Abstract] [Full Text] [Related] Page: [Next] [New Search]